CDI-DAYSYMS

Actelion Pharmaceuticals Ltd

Application Filed: 2016-11-16
Trademark Application Details
Trademark Logo CDI-DAYSYMS

Mark For: CDI-DAYSYMS® trademark registration is intended to cover the categories of printed questionnaires, namely, patient-reported outcomes paper questionnaires specific to Clostridium Difficile Associated Diarrhea. [all]

Status

2020-12-21 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number87975578
Registration Number6608712
Mark Literal ElementsCDI-DAYSYMS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED 2020-11-16
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 002: Receptacles
  • 005: Adhesives
  • 022: Games, Toys and Sporting Good
  • 023: Cutlery, Machinery, Tools and Parts Thereof
  • 029: Brooms, Brushes and Dusters
  • 037: Paper and Stationery
  • 038: Prints and Publications
  • 050: Merchandise Not Otherwise Classified
Primary International Class
  • 016 - Primary Class
  • (Paper goods and printed matter) Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); playing cards; printers' type; printing blocks.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeCheryl Foytlin
Attorney NameCheryl Foytlin
Attorney Docket NumberT41803US1
Law Office AssignedL80
Employee NameDAWE III, WILLIAM H

Timeline

2016-11-16Application Filed
2017-08-29Published
2017-08-29Published for Opposition
2017-10-24Location: INTENT TO USE SECTION
2019-10-23Status: Live/Pending
2019-10-25Transaction Date
2020-11-16Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
2020-11-16Status: A non-final Office Action has been sent (issued) to the applicant after review of the Statement of Use. This is a letter from th
2020-12-21Date of First Use
2020-12-21Date of Use In Commerce
2022-01-04Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Actelion Pharmaceuticals Ltd
AddressGewerbestrasse 16 Allschwil SWITZERLAND CH-4123
Legal Entity TypeSociété Anonyme (sa)
Legal Entity StateSWITZERLAND

Documents

DrawingJPEG2016-11-16
TEAS RF New ApplicationMULTI2016-11-16
Offc Action OutgoingMULTI2017-02-23
XSearch Search SummaryXML2017-02-23
Response to Office ActionMULTI2017-03-10
Amendment and Mail Process CompleteMULTI2017-03-30
Offc Action OutgoingMULTI2017-04-20
Request to DivideXML2017-06-13
Offc Action OutgoingXML2017-07-20
TRAM Snapshot of App at Pub for OppostnMULTI2017-07-21
Notice of PublicationXML2017-08-09
Notification Of Notice of PublicationXML2017-08-09
OG Publication ConfirmationXML2017-08-29
Notice of AllowanceXML2017-10-24
TEAS Rev, App and/or COA of Atty/Dom.RepXML2018-03-06
Extension of Time to File SOUXML2018-04-17
ITU Extension ApprovalAPPLICATION/XML2018-04-19
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2018-04-19
Extension of Time to File SOUXML2018-10-23
ITU Extension ApprovalXML2018-10-25
ITU Unit ActionMULTI2018-10-25
Extension of Time to File SOUXML2019-04-23
ITU Extension ApprovalXML2019-04-25
ITU Unit ActionMULTI2019-04-25
Extension of Time to File SOUXML2019-10-23
ITU Extension ApprovalXML2019-10-25
ITU Unit ActionMULTI2019-10-25
Extension of Time to File SOUMULTI2020-04-20
ITU Extension ApprovalXML2020-05-13
ITU Unit ActionMULTI2020-05-13
SpecimenJPEG2020-10-23
Statement of UseMULTI2020-10-23
ITU Unit ActionMULTI2020-10-27
Offc Action OutgoingXML2020-11-16

Attorney of Record

Cheryl Foytlin
Johnson & Johnson
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK NJ 08933

Good, Services, and Codes


IC 016. US 002 005 022 023 029 037 038 050. G & S: Printed questionnaires, namely, patient-reported outcomes paper questionnaires specific to Clostridium Difficile Associated Diarrhea. FIRST USE: 20170000. FIRST USE IN COMMERCE: 20170000

International Codes:9
U.S. Codes:021,023,026,036,038
International Codes:16
U.S. Codes:002,005,022,023,029,037,038,050
International Codes:45
U.S. Codes:100,101
Type CodeType
GS0091Computer software for generating and analyzing patient-reported outcomes e-questionnaires specific to Clostridium Difficile Associated Diarrhea
GS0161Printed questionnaires, namely, patient-reported outcomes paper questionnaires specific to Clostridium Difficile Associated Diarrhea

Trademark Filing History

DescriptionDateProceeding Number
SU - NON-FINAL ACTION - WRITTEN2020-11-1676838
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-11-16
NON-FINAL ACTION E-MAILED2020-11-16
STATEMENT OF USE PROCESSING COMPLETE2020-10-2670565
USE AMENDMENT FILED2020-10-2370565
TEAS STATEMENT OF USE RECEIVED2020-10-23
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-05-13
EXTENSION 5 GRANTED2020-05-1270565
TEAS EXTENSION RECEIVED2020-04-20
EXTENSION 5 FILED2020-04-2070565
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-25
TEAS EXTENSION RECEIVED2019-10-23
EXTENSION 4 GRANTED2019-10-2398765
EXTENSION 4 FILED2019-10-2398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-04-25
TEAS EXTENSION RECEIVED2019-04-23
EXTENSION 3 GRANTED2019-04-2398765
EXTENSION 3 FILED2019-04-2398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-10-25
TEAS EXTENSION RECEIVED2018-10-23
EXTENSION 2 GRANTED2018-10-2398765
EXTENSION 2 FILED2018-10-2398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-04-19
TEAS EXTENSION RECEIVED2018-04-17
EXTENSION 1 GRANTED2018-04-1798765
EXTENSION 1 FILED2018-04-1798765
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2018-03-06
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2018-03-06
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2017-10-24
PUBLISHED FOR OPPOSITION2017-08-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2017-08-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2017-08-09
DIVISIONAL PROCESSING COMPLETE2017-07-20
APPROVED FOR PUB - PRINCIPAL REGISTER2017-07-20
CASE ASSIGNED TO INTENT TO USE PARALEGAL2017-07-1470565
TEAS REQUEST TO DIVIDE RECEIVED2017-06-13
DIVISIONAL REQUEST RECEIVED2017-06-13
NOTIFICATION OF NON-FINAL ACTION E-MAILED2017-04-206325
NON-FINAL ACTION WRITTEN2017-04-2076838
NON-FINAL ACTION E-MAILED2017-04-206325
TEAS/EMAIL CORRESPONDENCE ENTERED2017-03-2970884
CORRESPONDENCE RECEIVED IN LAW OFFICE2017-03-2970884
ASSIGNED TO LIE2017-03-2470884
TEAS RESPONSE TO OFFICE ACTION RECEIVED2017-03-10
NOTIFICATION OF NON-FINAL ACTION E-MAILED2017-02-236325
NON-FINAL ACTION WRITTEN2017-02-2376838
NON-FINAL ACTION E-MAILED2017-02-236325
ASSIGNED TO EXAMINER2017-02-2376838
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2016-11-22
NEW APPLICATION ENTERED IN TRAM2016-11-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed